Obvio-19 17+
COVID-19 Immunity Study
Obvio Health USA Inc.
Designed for iPad
-
- Free
Screenshots
Description
The Obvio-19 app guides US participants through a pioneering research study designed to monitor COVID-19 exposure, symptoms, risk factors and immune response. You will be providing anonymized data that can help the scientific and medical community make smart policy, prevention and treatment decisions to protect the general and at-risk population from this terrible virus.
• Everyone is eligible
• Easy enrollment
• Tracks and record exposure, symptoms, medications, health history medical visits and tests through self-reported data.
What’s New
Version 1.5
Additional language and stability enhancements
App Privacy
The developer, Obvio Health USA Inc., has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Information
- Provider
- OBVIO HEALTH USA has not identified itself as a trader for this app. If you are a consumer in the European Economic Area, consumer rights do not apply to agreements between you and the provider.
- Size
- 59.5 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 11.0 or later.
- iPad
- Requires iPadOS 11.0 or later.
- iPod touch
- Requires iOS 11.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English, French, Japanese, Spanish
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © Obvio Health
- Price
- Free